Combination therapy improves response rates for chronic hepatitis B patients
Background and aims The optimal management strategy for adults with immune-tolerant (IT) chronic hepatitis B infection remains undefined.…
The HBsAg/HBV DNA ratio’s potential for predicting disease progression
Patients with chronic hepatitis B virus (HBV) infection in the immune-tolerant phase may still experience hepatic inflammation and…